Investigational Site Number 8409001

Wilmington, North Carolina 28401-6638

0 studies enrolling now · 1 studies all time

What they study most

Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control — Stopped early